Use of salvianolic acid A and medicine composition thereof from Salia miliiorrhiza Bge.
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A kind of technology of salvianolic acid and composition of salvia miltiorrhiza, applied in the field of traditional Chinese medicine
Inactive Publication Date: 2009-06-17
PHARMA RES INST OF BENCAO TIANYUAN OF BEIJING
View PDF0 Cites 2 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
[0008] Salvianolic acid A [salvianolic acid A] is one of the active ingredients of Danshen. Phenolic acid A has a good therapeutic effect on cardiovascular and cerebrovascular diseases, but so far, there is no literature report that salvianolic acid A or containing salvianolic acid A has the effect of treating arrhythmia
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0059] Salvianolic acid A, used to treat arrhythmia.
Embodiment 2
[0061] Using salvianolic acid A as a raw material, according to the conventional requirements of pharmacy, it is prepared into a pharmaceutically acceptable pharmaceutical preparation for treating arrhythmia.
Embodiment 3
[0063] A prescription that uses salvianolic acid A as the monarch drug or ministerial drug, and the ingredients compatible with salvianolic acid A include ginseng, Ophiopogon japonicus, dogwood, jujube seed, mulberry, red peony root, ground beetle, Gansong, coptis, Schisandra, Longgu, Scutellaria, Radix Isatidis, Folium Isatidis, Codonopsis, Poria, Atractylodes macrocephala, Chuanqin, Astragalus, Baiziren, Double Flower, Bupleurum, Cundong, Panax notoginseng, Aconite, Guizhi, Asarum, Ephedra, Epimedium Huo, Licorice, Sophora flavescens, Hawthorn, Polygonatum and other active ingredients or one or more of the effective parts of traditional Chinese medicines to form a pharmaceutical composition for treating arrhythmia.
[0064] Alternatively, the above-mentioned pharmaceutical composition is used as a raw material to prepare a pharmaceutically acceptable pharmaceutical preparation according to the conventional requirements of pharmacy for treating arrhythmia.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The present invention discloses salvianolic acid A and a novel use of pharmaceutical composition comprising salvianolic acid A. The invention is characterized by the application of salvianolic acid A in preparing the medicament for treating arrhythmia, and the application of pharmaceutical composition composed of salvianolic acid A, ginseng, ophiopogon root, cornus officinalis, quinidine, lignocaine, etc. in preparing the medicament for treating arrhythmia. The pharmaceutical and clinical researches show that the salvianolic acid A and pharmaceutical composition comprising salvianolic acid A have excellent treating function for arrhythmia.
Description
technical field [0001] The invention relates to the field of traditional Chinese medicine, and relates to a new medical application of salvianolic acid A and a pharmaceutical composition containing salvianolic acid A. [0002] The arrhythmia described in the present invention mainly refers to common heart arrhythmia in clinical hospitals. [0003] The arrhythmia mentioned in the present invention refers to any abnormality of heart rhythm origin, heart rate and rhythm, and impulse conduction. [0004] The arrhythmia mentioned in the present invention mainly refers to the abnormality of the frequency, rhythm, origin site, conduction velocity or excitation sequence of cardiac impulses. According to the principle of its occurrence, it can be divided into two categories: abnormal impulse formation and abnormal impulse conduction. Abnormal impulse formation: (1) sinus arrhythmia 1, sinus tachycardia; 2, sinus bradycardia; 3, sinus arrhythmia; 4, sinus arrest; (2) ectopic rhythm 1,...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/216A61P9/06
Inventor 顾群栗艳彬鄯慧珍李志刚渠守峰
Owner PHARMA RES INST OF BENCAO TIANYUAN OF BEIJING